NewAmsterdam Pharma Company NAMS Goodwill and intangible assets, net
Goodwill and intangible assets, net at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's goodwill and intangible assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's goodwill and intangible assets, net?
- NewAmsterdam Pharma Company (NAMS) reported goodwill and intangible assets, net of $375K in Q1 2026.
- How has NewAmsterdam Pharma Company's goodwill and intangible assets, net changed year-over-year?
- NewAmsterdam Pharma Company's goodwill and intangible assets, net decreased by 25.3% year-over-year, from $502K to $375K.
- What is the long-term trend for NewAmsterdam Pharma Company's goodwill and intangible assets, net?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's goodwill and intangible assets, net has grown at a 25.1% compound annual growth rate (CAGR), from $208K to $407K.